Taiwan-based startup Brain Navi Biotechnology, a leading innovator in neurosurgical robotics, has announced a strategic partnership with BenQ Medical Technology to introduce and commercialise the NaoTrac neurosurgical navigation robot in the Chinese market. This collaboration aligns with Brain Navi's 2025 globalisation strategy, prioritising localised partnerships to accelerate market entry and enhance clinical adoption.
Through this partnership, BenQ Medical Technology will leverage its extensive hospital network across China to facilitate NaoTrac's clinical deployment. This collaboration is further supported by China's 14th Five-Year Plan for the Development of the Medical Equipment Industry, which aims to foster domestic innovation and promote intelligent medical solutions.
Dr Jerry Chen, CEO of Brain Navi, emphasised the importance of regional partnerships, stating, "NaoTrac has been used in some medical centres across Asia, Latin America, and Europe. Partnering with BenQ Medical Technology gives us a robust gateway into the Chinese market, where localisation is key to success. By combining our AI-driven surgical technology with BenQ Medical Technology's strong market presence, we are confident in accelerating the adoption of neurosurgical robotics in China."
As part of its 2025 strategy, Brain Navi continues to expand its global footprint, with current key focus areas in EMEA, the Asia-Pacific region, and Latin America. By fostering strong alliances with distributors and hospital networks, the company ensures the seamless integration of neurosurgical robotics into regional healthcare systems.
